What’s next for AI strategy at an FDA buffeted by leadership shifts - Pharma Voice

The FDA's approach to regulating AI in healthcare is uncertain due to leadership changes. This matters to patients and professionals because the FDA approves treatments and medical devices that affect healthcare safety and access.